Abstract |
The leukaemia cell line HL60 is widely used in studies of the cell cycle, apoptosis and adhesion mechanisms in cancer cells. One marked characteristic of HL60 cells is the c-MYC proto-oncogene amplification, resulting in the formation of homogeneously staining regions (HSRs) at 8p24. We conducted a fluorescence in situ hybridization study in an HL60 cell line, using a locus-specific probe for c-MYC, before and after treatment with pisosterol (at 0.5, 1.0 and 1.8 microg/mL), a triterpene isolated from the fungus Pisolithus tinctorius. Before treatment, 87.5% of the cells showed HSRs. After treatment, no effects were detected at lower concentrations of pisosterol (0.5 and 1.0 microg/mL). However, at 1.8 microg/mL only 15% of the cells presented HSRs, and 39.5% presented few fluorescent signals (3 or 4 alleles), suggesting that pisosterol probably blocks the cells with HSRs at interphase. This result is particularly interesting because cells that do not show a high degree of c-MYC gene amplification have a less aggressive and invasive behaviour and are easy targets for chemotherapy. Therefore, further studies are needed to examine the use of pisosterol in combination with conventional anti- cancer therapy.
|
Authors | T C R Silva, P D L Lima, M O Bahia, A S Khayat, F S Bezerra, M Andrade-Neto, A D Seabra, T B Pontes, M O Moraes, R C Montenegro, L V Costa-Lotufo, C Pessoa, G R Pinto, R R Burbano |
Journal | Human & experimental toxicology
(Hum Exp Toxicol)
Vol. 29
Issue 3
Pg. 235-40
(Mar 2010)
ISSN: 1477-0903 [Electronic] England |
PMID | 20071475
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- MAS1 protein, human
- MYC protein, human
- Proto-Oncogene Mas
- Proto-Oncogene Proteins c-myc
- Terpenes
- pisosterol
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Dose-Response Relationship, Drug
- Gene Amplification
- Gene Expression Regulation, Neoplastic
- HL-60 Cells
- Humans
- In Situ Hybridization, Fluorescence
- Interphase
- Proto-Oncogene Mas
- Proto-Oncogene Proteins c-myc
(genetics)
- Terpenes
(pharmacology)
|